Related references
Note: Only part of the references are listed.DNA methylation profile of genes related to immune response in generalized periodontitis
Andrea Mara Azevedo et al.
JOURNAL OF PERIODONTAL RESEARCH (2020)
Myelodysplastic Syndromes
Mario Cazzola
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Overview on Osteoporosis, Periodontitis and Oral Dysbiosis: The Emerging Role of Oral Microbiota
Maria Contaldo et al.
APPLIED SCIENCES-BASEL (2020)
A dual role of TGF-β in human osteoclast differentiation mediated by Smad1 versus Smad3 signaling
Bitnara Lee et al.
IMMUNOLOGY LETTERS (2019)
Epigenetic and inflammatory events in experimental periodontitis following systemic microbial challenge
Daniela B. Palioto et al.
JOURNAL OF CLINICAL PERIODONTOLOGY (2019)
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
Courtney D. DiNardo et al.
BLOOD (2019)
KLF2 regulates osteoblast differentiation by targeting of Runx2
Zhenyang Hou et al.
LABORATORY INVESTIGATION (2019)
Epigenetics and periodontics: A systematic review
Pedro J. Alminana-Pastor et al.
MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL (2019)
Gene Modification of Transforming Growth Factor β (TGF-β) and Interleukin 10 (IL-10) in Suppressing Mt Sonicate Induced Osteoclast Formation and Bone Absorption
Lankai Yi et al.
MEDICAL SCIENCE MONITOR (2018)
Dynamics of clonal evolution in myelodysplastic syndromes
Hideki Makishima et al.
NATURE GENETICS (2017)
Lipopolysaccharide Downregulates Kruppel-Like Factor 2 (KLF2) via Inducing DNMT1-Mediated Hypermethylation in Endothelial Cells
Zhonghai Yan et al.
INFLAMMATION (2017)
The case for periodontitis in the pathogenesis of rheumatoid arthritis
Jan Potempa et al.
NATURE REVIEWS RHEUMATOLOGY (2017)
Nonsurgical and surgical treatment of periodontitis: how many options for one disease?
Filippo Graziani et al.
PERIODONTOLOGY 2000 (2017)
Randomized Placebo-Controlled and Controlled Non-Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects
Masahiro Kitamura et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2016)
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
J. S. Welch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Decitabine represses osteoclastogenesis through inhibition of RANK and NF-κB
Hanfeng Guan et al.
CELLULAR SIGNALLING (2015)
TLR2 Promoter Hypermethylation Creates Innate Immune Dysbiosis
M. Benakanakere et al.
JOURNAL OF DENTAL RESEARCH (2015)
Modifiable risk factors in periodontal disease Epigenetic regulation of gene expression in the inflammatory response
Silvana P. Barros et al.
PERIODONTOLOGY 2000 (2014)
Kruppel-Like Factor 2 Is a Transcriptional Regulator of Chronic and Acute Inflammation
Lalitha Nayak et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Hypermethylation and low transcription of TLR2 gene in chronic periodontitis
Simone Angelica de Faria Amormino et al.
HUMAN IMMUNOLOGY (2013)
Optimization of the ligature-induced periodontitis model in mice
Toshiharu Abe et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2013)
Epigenetic Regulation of TNFA Expression in Periodontal Disease
Shaoping Zhang et al.
JOURNAL OF PERIODONTOLOGY (2013)
Epigenetic biomarkers: a step forward for understanding periodontitis
Anders M. Lindroth et al.
JOURNAL OF PERIODONTAL AND IMPLANT SCIENCE (2013)
Advanced reconstructive technologies for periodontal tissue repair
Christoph A. Ramseier et al.
PERIODONTOLOGY 2000 (2012)
DNA Methylation Status of the IL8 Gene Promoter in Aggressive Periodontitis
Denise C. Andia et al.
JOURNAL OF PERIODONTOLOGY (2010)
Genetic and environmental risk factors for chronic periodontitis and aggressive periodontitis
Ayala Stabholz et al.
PERIODONTOLOGY 2000 (2010)
Multicenter Study of Decitabine Administered Daily for 5 Days Every 4 Weeks to Adults With Myelodysplastic Syndromes: The Alternative Dosing for Outpatient Treatment (ADOPT) Trial
David P. Steensma et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
Pierre Fenaux et al.
LANCET ONCOLOGY (2009)
Epigenetics: A landscape takes shape
Aaron D. Goldberg et al.
CELL (2007)
Bacterial infection promotes DNA hypermethylation
Y. A. Bobetsis et al.
JOURNAL OF DENTAL RESEARCH (2007)
Kruppel-like factor 2 (KLF2) regulates proinflammatory activation of monocytes
H Das et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Decitabine improves patient outcomes in myelodysplastic syndromes - Resuits of a Phase III randomized study
H Kantarjian et al.
CANCER (2006)
Accelerated alveolar bone loss in mice lacking interleukin-10: late onset
A Al-Rasheed et al.
JOURNAL OF PERIODONTAL RESEARCH (2004)
Accelerated alveolar bone loss in mice lacking interleukin-10
A Al-Rasheed et al.
JOURNAL OF DENTAL RESEARCH (2003)
5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation:: mechanistic studies and their implications for cancer therapy
JK Christman
ONCOGENE (2002)
Enamel matrix proteins in the regenerative therapy of deep intrabony defects - A multicentre randomized controlled clinical trial
MS Tonetti et al.
JOURNAL OF CLINICAL PERIODONTOLOGY (2002)
Share Paper
